Drug intelligence / Profile preview

plasma-lyte 148 + dextrose

Development stage
Phase 4
Lead developer
Baxter Healthcare Corporation
Modality
Small Molecules
Administration
Intravenous
01

Overview

Plasma-lyte 148 + dextrose is an intravenous crystalloid solution used for fluid resuscitation and maintenance therapy. It consists of Plasma-lyte 148, a balanced, isotonic electrolyte solution containing sodium, potassium, magnesium, chloride, acetate, and gluconate, supplemented with dextrose (glucose). The electrolyte composition is designed to closely resemble human plasma, with acetate and gluconate serving as bicarbonate precursors to provide a buffering effect against acidosis. The addition of dextrose provides a caloric source to prevent ketosis and hypoglycemia. This combination is particularly utilized in pediatric and acutely ill populations to maintain hemodynamic stability and electrolyte balance while minimizing the risk of iatrogenic hyponatremia.

Brand names
Plasma-Lyte 148 and 5% DextrosePlasma-Lyte 148 with 5% Dextrose
Other names
PL148 + D5Electrolytes Injection Type 1 with Dextroseplasma-lyte 148 + dextrose
02

Targets

ClC (CLC chloride channel family)

Beyond the preview

Go deeper on plasma-lyte 148 + dextrose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on plasma-lyte 148 + dextrose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call